284 related articles for article (PubMed ID: 16235286)
1. Preoperative radiotherapy for esophageal carcinoma.
Arnott SJ; Duncan W; Gignoux M; Hansen HS; Launois B; Nygaard K; Parmar MK; Rousell A; Spilopoulos G; Stewart G; Tierney JF; Wang M; Rhugang Z;
Cochrane Database Syst Rev; 2005 Oct; 2005(4):CD001799. PubMed ID: 16235286
[TBL] [Abstract][Full Text] [Related]
2. Preoperative radiotherapy for esophageal carcinoma.
Arnott SJ; Duncan W; Gignoux M; Girling DJ; Hansen HS; Launois B; Nygaard K; Parmar MK; Rousell A; Spiliopoulos G; Stewart LA; Tierney JF; Wang M; Rhugang Z;
Cochrane Database Syst Rev; 2000; (4):CD001799. PubMed ID: 11034728
[TBL] [Abstract][Full Text] [Related]
3. Preoperative radiotherapy for esophageal carcinoma. Oeosphageal Cancer Collaborative Group.
Arnott SJ; Duncan W; Gignoux M; Girling DJ; Hansen HS; Launois B; Nygaard K; Parmar MK; Rousell A; Spiliopoulos G; Stewart LA; Tierney JF; Wang M; Rhugang Z
Cochrane Database Syst Rev; 2000; (2):CD001799. PubMed ID: 10796823
[TBL] [Abstract][Full Text] [Related]
4. Preoperative radiotherapy in esophageal carcinoma: a meta-analysis using individual patient data (Oesophageal Cancer Collaborative Group).
Arnott SJ; Duncan W; Gignoux M; Girling DJ; Hansen HS; Launois B; Nygaard K; Parmar MK; Roussel A; Spiliopoulos G; Stewart LA; Tierney JF; Mei W; Rugang Z
Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):579-83. PubMed ID: 9635705
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Preoperative chemotherapy for resectable thoracic esophageal cancer.
Malthaner R; Fenlon D
Cochrane Database Syst Rev; 2001; (1):CD001556. PubMed ID: 11279723
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy for resected early-stage non-small cell lung cancer.
Burdett S; Pignon JP; Tierney J; Tribodet H; Stewart L; Le Pechoux C; Aupérin A; Le Chevalier T; Stephens RJ; Arriagada R; Higgins JP; Johnson DH; Van Meerbeeck J; Parmar MK; Souhami RL; Bergman B; Douillard JY; Dunant A; Endo C; Girling D; Kato H; Keller SM; Kimura H; Knuuttila A; Kodama K; Komaki R; Kris MG; Lad T; Mineo T; Piantadosi S; Rosell R; Scagliotti G; Seymour LK; Shepherd FA; Sylvester R; Tada H; Tanaka F; Torri V; Waller D; Liang Y;
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD011430. PubMed ID: 25730344
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy for non-small cell lung cancer.
Non-small Cell Lung Cancer Collaborative Group
Cochrane Database Syst Rev; 2000; 2000(2):CD002139. PubMed ID: 10796867
[TBL] [Abstract][Full Text] [Related]
9. Postoperative radiotherapy for non-small cell lung cancer.
PORT Meta-Analysis Trialists Group
Cochrane Database Syst Rev; 2003; (1):CD002142. PubMed ID: 12535431
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy for high-grade glioma.
Glioma Meta-Analysis Trialists (GMT) Group
Cochrane Database Syst Rev; 2002; (4):CD003913. PubMed ID: 12519620
[TBL] [Abstract][Full Text] [Related]
11. Postoperative radiotherapy for non-small cell lung cancer.
PORT Meta-analysis Trialists Group
Cochrane Database Syst Rev; 2000; (2):CD002142. PubMed ID: 10796868
[TBL] [Abstract][Full Text] [Related]
12. Postoperative radiotherapy for non-small cell lung cancer.
Burdett S; Rydzewska L; Tierney J; Fisher D; Parmar MK; Arriagada R; Pignon JP; Le Pechoux C;
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD002142. PubMed ID: 27727451
[TBL] [Abstract][Full Text] [Related]
13. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis.
Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration (CCCMAC)
Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD008285. PubMed ID: 20091664
[TBL] [Abstract][Full Text] [Related]
14. Preoperative chemotherapy for resectable thoracic esophageal cancer.
Kidane B; Coughlin S; Vogt K; Malthaner R
Cochrane Database Syst Rev; 2015 May; 2015(5):CD001556. PubMed ID: 25988291
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis.
Malthaner RA; Wong RK; Rumble RB; Zuraw L;
BMC Med; 2004 Sep; 2():35. PubMed ID: 15447788
[TBL] [Abstract][Full Text] [Related]
16. Postoperative radiotherapy for non-small cell lung cancer.
PORT Meta-analysis Trialists Group
Cochrane Database Syst Rev; 2005 Apr; (2):CD002142. PubMed ID: 15846628
[TBL] [Abstract][Full Text] [Related]
17. Preoperative chemotherapy for resectable thoracic esophageal cancer.
Malthaner RA; Collin S; Fenlon D
Cochrane Database Syst Rev; 2006 Jul; (3):CD001556. PubMed ID: 16855972
[TBL] [Abstract][Full Text] [Related]
18. WITHDRAWN: Neoadjuvant cisplatin for advanced bladder cancer.
Advanced Bladder Cancer Meta-analysis Collaboration
Cochrane Database Syst Rev; 2011 Jun; 2011(6):CD001426. PubMed ID: 21678333
[TBL] [Abstract][Full Text] [Related]
19. Preoperative chemotherapy for resectable thoracic esophageal cancer.
Malthaner R; Fenlon D
Cochrane Database Syst Rev; 2003; (4):CD001556. PubMed ID: 14583936
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant platinum-based chemotherapy for early stage cervical cancer.
Falcetta FS; Medeiros LR; Edelweiss MI; Pohlmann PR; Stein AT; Rosa DD
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD005342. PubMed ID: 27873308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
